Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2017 (2017), Article ID 8645859, 4 pages
Case Report

Acute Bacterial Meningitis and Systemic Abscesses due to Streptococcus dysgalactiae subsp. equisimilis Infection

1Department of Intensive Care, Cliniques St-Luc, Université Catholique de Louvain, Brussels, Belgium
2Department of Radiology, Neuroradiology Division, Cliniques St-Luc, Université Catholique de Louvain, Brussels, Belgium
3Department of Nuclear Medicine, Cliniques St-Luc, Université Catholique de Louvain, Brussels, Belgium
4Laboratory of Microbiology, Cliniques St-Luc, Université Catholique de Louvain, Brussels, Belgium

Correspondence should be addressed to P. Hantson; eb.niavuolcu@nostnah.eppilihp

Received 20 February 2017; Accepted 11 April 2017; Published 23 April 2017

Academic Editor: Raul Colodner

Copyright © 2017 M. Jourani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Disseminated abscesses due to group G β-hemolytic Streptococcus dysgalactiae were observed in a 57-year-old cirrhotic patient with the skin being the putative way of entry for the pathogen. S. dysgalactiae is a rare agent in human infections responsible for acute pyogenic meningitis. The mortality rate associated with S. dysgalactiae bacteraemia and meningitis may be as high as 50%, particularly in the presence of endocarditis or brain abscesses. In our patient, main sites of infections were meningitis and ventriculitis, spondylodiscitis, septic arthritis, and soft-tissue infections. In contrast, no endocarditis was evidenced. Cirrhosis-related immune suppression was considered as a pathophysiological cofactor for the condition. Fortunately, clinical status improved after long-term (3 months) antimicrobial therapy.

1. Introduction

Meningitis due to Streptococcus dysgalactiae has been reported in a very restricted number of adult or pediatric cases, usually with a mild clinical course [17]. It is usually thought that streptococcal meningitis is acquired via transient colonization of the nasopharynx, followed by bacteraemia and subsequent invasion of the central nervous system (CNS). Although invasive infection (including shock, renal and liver involvement, and soft-tissue necrosis, but not meningitis) caused by Japanese strains of S. dysgalactiae has been reported, S. dysgalactiae usually carries a low pathogenic potential [8]. We describe a case of S. dysgalactiae bacteraemia complicated by meningitis and disseminated abscesses in a cirrhotic patient with favorable outcome.

2. Case Report

A 57-year-old man was found lying on the floor of his room. He had a medical history of heavy chronic ethanol consumption (more than 10 units/day for 30 years) but never underwent hepatic investigations. More than 10 years ago, he had had prosthetic replacement of the right knee. He had also received dental care more than two months before symptoms onset. A few weeks before hospital admission, he had a traumatic fracture of the right calcaneus treated by plaster cast immobilization.

At admission to Emergency Department, he presented with a left-sided hemiparesis, dysarthria, and confusion. Glasgow coma scale (GCS) score was calculated at 13/15 (E4, V3, M6). There was a mild meningeal irritation. The body temperature was 36.7°C, and blood pressure was 125/66 mmHg. Examination of the pharynx was unremarkable. After cast removal, a cellulitis of the right leg was diagnosed together with a thrombosis of the right posterior tibial and peroneal veins. Antimicrobial treatment was immediately initiated with intravenous amoxicillin-clavulanic acid (1 g every 6 h). Both knees were swollen, erythematous, and painful, as well as both elbows, and multifocal septic arthritis was suspected.

Laboratory investigations showed a C-reactive protein (CRP) at 333 mg/dL (normal value < 5 mg/L) and white blood cell count of 19850 cells/mm3 (95.1% granulocytes). Other standard laboratory findings were within normal range, except for an international normalized ratio (INR) at 2.37, and serum CK level at 1569 IU/l (normal value < 200). Microscopic hematuria and mild proteinuria were noted at urine analysis. The brain computed tomography (CT) scan did not reveal any specific lesion as well as fundoscopic examination. A lumbar puncture was performed and cerebrospinal fluid (CSF) examination showed white blood cells count of 1127 cells/mm3 (64% granulocytes), glucose not detectable, and protein of 1848 mg/dL. The CSF Gram-staining revealed the presence of rare white blood cells but no organism. Two sets of blood cultures were positive for S. dysgalactiae, while CSF culture remained sterile after seven days of incubation including enriched culture media. S. dysgalactiae was not isolated from the skin, nose, and throat swaps. Blood cultures became sterile 24 hours after the start of antimicrobial therapy. The universal PCR 16S rRNA gene sequencing (qPCR16S) using SQ1-S (50-AgAgTTTgATCCTggCTCAg-30), SQ1-AS (50-AAggAGGTgATCCARCCgCA-30), SQ2-AS (5′-gggTTgCgCTCgTTG-30), and SQ3-AS 50-TCTACgCATTTCACCgCTAC-3 primers (96GA3730 XL, Applied Biosystem, USA) applied directly to CSF samples was negative. There was no evidence of endocarditis at echocardiography.

Surgical treatment was required for the right prosthetic knee and culture of purulent material yielded S. dysgalactiae subsp. equisimilis. Aerobic and anaerobic cultures of purulent material from the left knee and both elbows remained sterile after seven days of incubation.

The search for metastatic foci included total body computed tomography (CT) scan examination, spine and brain magnetic resonance imaging (MRI), and total body fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET-CT).

Brain magnetic resonance imaging (MRI) was performed on admission and three weeks later and was consistent with acute ventriculitis without evidence of brain abscesses (Figure 1).

Figure 1: (a-b) Admission brain MRI; (c-d) follow-up brain MRI three weeks later. (a) Contrast-enhanced (CE) axial transverse fluid-attenuated inversion-recovery (FLAIR) view at admission showing diffuse abnormal enhancement of ependyma (white arrow) and bilateral fluid-fluid level at trigonal areas of lateral ventricles (black arrow). (b) Admission diffusion-weighted (DW) axial transverse view at admission at similar slice location as in (a) showing high signal intensity within declive sediment of the fluid-fluid level featuring pus with free water diffusivity restriction (dotted arrows). (c) CE FLAIR view in similar slice location as in (a) three weeks later showing complete subsidence of ependymal contrast-enhancement (white arrow) and disappearance of the fluid-fluid levels (black arrow). Only persistent enhanced brightness of ependymal lining was seen. (d) DW image in similar slice location as in (b) showing only minimal purulent residue within left ventricular trigone (dotted arrow).

FDG PET-CT revealed multiple areas of hypermetabolic activity in joints, soft tissues, and spine corresponding to disseminated infection (Figure 2). Mainly, L2-L3 intervertebral space, sternoclavicular joints, knees, left hip, elbows, left shoulder, left deltoid muscle, right subscapularis muscle, left obturator internus muscle, and gluteal muscles were involved. No abnormal metabolic activity was observed in the cardiac area and no abnormal FDG uptake leading to cancer suspicion was observed. No abnormal metabolic activity was observed in the cardiac area and no abnormal FDG uptake leading to cancer suspicion was observed.

Figure 2: (a) MIP (maximum intensity projection) of FDG PET showing multiple areas of hypermetabolic activity corresponding to disseminated foci of infection and (b) transaxial views of CT, fused FDG PET-CT and FDG PET images representative of several foci of infection disseminated in joints, soft tissues, and lumbar column (arrows).

In addition, spinal MRI demonstrated diffuse and severe intrathecal inflammatory changes together with a L2-L3 spondylodiscitis with only moderate involvement of adjacent epidural spaces (not shown).

On day 3, antimicrobial therapy was switched to intravenous ceftriaxone (2 g/every 12 h) and ampicillin (1 g/every 6 h) and thereafter to rifampicin 600 mg/day. Hepatic fibrosis stage F4 was diagnosed by ultrasound elastography (FibroScan®). At 3-month follow-up, the patient had a complete functional recovery normalized inflammatory markers, and antimicrobial therapy was thereafter discontinued.

3. Discussion

Streptococcus dysgalactiae subsp. equisimilis is a human-pathogenic betahaemolytic pyogenic Streptococcus harboring the Lancefield group G, C, or L antigens. Pathogenic strains harbor virulence genes similar to virulence genes to S. pyogenes and have been associated with upper respiratory tract infection (pharyngitis, mainly in children), skin and soft-tissue infections, and invasive infections. While Streptococcus dysgalactiae subsp. equisimilis may belong to the commensal oropharyngeal flora, invasive infections may be caused by person-to-person transmission [9]. An increasing number of patients with severe invasive S. dysgalactiae infection have been observed in Japan during the early 2000s [8]. The clinical course included shock and a varying number of patients with renal impairment, disseminated intravascular coagulation, liver involvement, adult respiratory distress syndrome (ARDS), generalized erythematous macular rash, and soft-tissue necrosis. The strains did not seem to expand clonally but they were carrying specific genes-related virulence (scpA, ska, slo, and sag genes). People developing a severe infection with this organism were likely to suffer cancer in 21–65% of cases or to be immunocompromised by diabetes mellitus, cirrhosis, or alcohol abuse [1014].

Acute bacterial meningitis could result either by hematogenous spreading to the CNS or from a local extension to the subarachnoid spaces [15]. It seems important to exclude the presence of cerebral abscesses when meningitis is diagnosed and to look for endocarditis, which is present in most cases of group G Streptococcus meningitis. The mortality rate associated with group G Streptococcus meningitis is not precisely established but could be as high as 50%. In the hereby reported case, endocarditis could be ruled out by repeatedly negative cardiac echography. In the case reported here, CSF culture and universal 16S rRNA PCR were negative. Because of low sensitivity and false positive and negative results, the qPCR16S test applied directly in samples should be interpreted with caution and needs the use in parallel of microbiological cultures. However, the final diagnosis of bacterial meningitis which is generally based on CSF microbiological cultures can be inconclusive in 20% of cases of patients with community bacterial acquired meningitis, rising to less than 50% of cases if patients have received prior antimicrobial therapy. In the present observation, hematogenous origin of meningeal infection was considered more likely than focal contamination from epidural infection.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.


  1. C. Luyx, D. Vanpee, Y. Glupczynski, C. Swine, and J.-B. Gillet, “Delayed diagnosis of meningitis caused by β-haemolytic group G Streptococcus in an older woman,” Journal of Emergency Medicine, vol. 21, no. 4, pp. 393–396, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Berenguer, I. Sampedro, E. Cercenado, J. Baraia, M. Rodríguez-Créixems, and E. Bouza, “Group-C β-hemolytic streptococcal bacteremia,” Diagnostic Microbiology and Infectious Disease, vol. 15, no. 2, pp. 151–155, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. L. C. Mollison and E. Donaldson, “Group C streptococcal meningitis,” The Medical Journal of Australia, vol. 152, pp. 319–320, 1990. View at Google Scholar
  4. S. J. Chung, “Meningitis caused by streptococcus equisimilis (group C),” Southern Medical Journal, vol. 75, no. 6, p. 769, 1982. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Waltereit, U. Herrlinger, M. Stark, and S. Borgmann, “Meningitis in a pregnant woman caused by Streptococcus dysgalactiae subspecies equisimilis,” Polish Journal of Microbiology, vol. 62, no. 2, pp. 217–219, 2013. View at Google Scholar · View at Scopus
  6. J. A. Hervás, M. V. Labay, G. Rul-lán, L. Aguilar, J. Gil, and P. Alomar, “Neonatal sepsis and meningitis due to streptococcus equisimilis,” The Pediatric Infectious Disease Journal, vol. 4, pp. 694–695, 1985. View at Publisher · View at Google Scholar
  7. R. J. M. Quinn, A. F. Hallett, P. C. Appelbaum, and R. C. Cooper, “Meningitis caused by Streptococcus dysgalactiae in a preterm infant,” American Journal of Clinical Pathology, vol. 70, no. 6, pp. 948–950, 1978. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Ikebe, S. Murayama, K. Saitoh et al., “Surviellance of severe invasive group-G streptococcal infections and molecular typing of the isolates in Japan,” Epidemiology and Infection, vol. 132, no. 1, pp. 145–149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Sunaoshi, S. Y. Murayama, K. Adachi et al., “Molecular emm genotyping and antibiotic susceptibility of Streptococcus dysgalactiae subsp. equisimilis isolated from invasive and non-invasive infections,” Journal of Medical Microbiology, vol. 59, no. 1, pp. 82–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Vartian, P. I. Lerner, D. M. Shlaes, and K. V. Gopalakrishna, “Infections due to lancefield group G Streptococci,” Medicine (Baltimore), vol. 64, no. 2, pp. 75–88, 1985. View at Google Scholar · View at Scopus
  11. C. E. Liu, T. N. Jang, F. D. Wang, L. S. Wang, and C. Y. Liu, “Invasive group G streptococcal infections: a review of 37 cases,” Chung Hua I Hsueh Tsa Chih (Taipei), vol. 56, pp. 173–178, 1995. View at Google Scholar
  12. F. R. Venezio, R. M. Gullberg, G. O. Westenfelder, J. P. Phair, and F. V. Cook, “Group G streptococcal endocarditis and bacteremia,” The American Journal of Medicine, vol. 81, no. 1, pp. 29–34, 1986. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Auckenthaler, P. E. Hermans, and J. A. Washington, “Group G streptococcal bacteremia: clinical study and review of the literature,” Reviews of Infectious Diseases, vol. 5, no. 2, pp. 196–204, 1983. View at Publisher · View at Google Scholar · View at Scopus
  14. K. L. Watsky, N. Kollisch, and P. Densen, “Group G Streptococcal Bacteremia: the clinical experience at Boston university medical center and a critical review of the literature,” Archives of Internal Medicine, vol. 145, no. 1, pp. 58–61, 1985. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Møller, E. Harder Frederiksen, J. Heugh Wandall, and P. Skinhøj, “Meningitis caused by streptococci other than Streptococcus pneumoniae: a retrospective clinical study,” Scandinavian Journal of Infectious Diseases, vol. 31, no. 4, pp. 375–381, 1999. View at Publisher · View at Google Scholar · View at Scopus